News

Deutsche Börse Venture Network and High-Tech Gründerfonds (HTGF) have formalised their existing collaboration by signing a cooperation agreement. The aim of the partnership is to continue linking existing programmes with each other to closely support start-ups throughout their entire funding and growth phase. HTGF is the first point of contact for all matters relating to early stage financing; the portfolio companies receive a reduced-rate membership in Deutsche Börse Venture Network, givi

German DroneTech company FlyNex, founded by former special ops officers, raises big seed round. The co-investment by TGFS and HTGF ensures the implementation of the drone business software into industrial enterprises. The software empowers these companies to use drones for own applications, without having deeper technological and legal knowledge. The DroneTech start up FlyNex closes a seven-digit seed round and extends its offices in Leipzig and Hamburg. With a co-investment by Technologiegr�

In the field of dermatology, Zimmer MedizinSysteme GmbH, a company based in Neu-Ulm (southern Germany), has long been the global market leader for cryotherapy products. In founding the spin-off Zimmer BioTech, the company is now taking another step forward and utilising its wealth of experience to treat skin cancer. Together with High-Tech Gründerfonds (HTGF), the medical device producer is investing in the development of a drug based on the compound 5-Aminolevulinic acid (ALA), which is used i

The industrial biotechnology company evoxx technologies GmbH has become a part of the leading specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a binding agreement about the acquisition of 100% stake in evoxx technologies. evoxx technologies is proud to announce that it will become part of the global enzyme manufacturing company Advanced Enzyme Technologies Limited. evoxx and its team of 35+ scientists & technicians across

German HTGF acts as seed investor at stimOS GmbH located in Constance: Together with MBG, Baden-Württemberg (MBG), the seed stage investor provides 720,000 euros for further development and approval of stimOS’ patented Mimicking Bone Technology (MBT). To ensure best possible recovery for the patient and achieve a pain-free life after surgery, stimOS GmbH has developed a unique biochemical procedure that initiates early and healthy bone formation, anti-inflammatory activity, and faster healing

Dutch sustainable energy company Eneco Group has acquired a minority interest of 34% in Germany-based Next Kraftwerke, operator of one of the largest Virtual Power Plants (VPP) in Europe. The investment will allow for the further strategic expansion of Next Kraftwerke in Europe and contribute to the joint ambition of Eneco Group and Next Kraftwerke to accelerate the energy transition by means of technology, enabling more renewable and decentralized energy. Next Kraftwerke, founded in 2009 in

Technologiegründerfonds Sachsen (TGFS) and High-Tech Gründerfonds (HTGF) are investing in the fast-growing sector of smart farming. Lely Group has also agreed a strategic partnership with the company. Dresden-based start-up fodjan is a specialist in the field of efficient feed management for livestock. The firm's smart, cloud-based software makes it possible to reduce feed costs, increase operational efficiency while also improving animal health. After securing financing for his company,

Four investors are financing continued growth by i3 Membrane GmbH. High-Tech Gründerfonds (HTGF) in Bonn, Innovationsstarter Fonds in Hamburg, Mittelständische Beteiligungsgesellschaft Sachsen mbH (MBG) in Dresden and a private US investor are investing a 7-digit Euro sum in further developing and launching new filters and separation technologies. Ultra-thin metal coatings on conventional membranes can be charged with electric current to capture charged nanoparticles such as viruses and cytoto

AudioCure, a pharmaceutical R&D company headquartered in Germany, announces today that it has secured an A-round of about EUR 9 million from MED-EL, HTGF and private investors. MED-EL receives exclusive licensing rights and shares while existing investors increase their shares. AudioCure will use the funding to get its front-runner small molecule AC102 into Phase I clinical trials in auditory disorders including acute hearing loss and acute tinnitus. To date, there are no approved therapeuti

There is a growing need for innovation in the health system, but at the same time it is challenging to establish new healthcare solutions for the market. Many stakeholders such as insurance companies, investors and start-ups currently opt for alternative methods to achieve their goals. In its seventh issue, the media service “MedTech Radar”, a joint publication of the German Medical Technology Association BVMed, Earlybird Venture Capital, the High-Tech Gründerfonds and BIOCOM AG, reports on

The leading network provider Vodafone GmbH acquires 100 percent of the shares in Dresden based RadioOpt GmbH, a specialist for crowd based analysis of network per-formance using smartphone applications. RadioOpt, established in 2008, is THE partner for performance data at smartphone level. For this purpose, device and network dependent data on the availability and performance of mo-bile and WLAN networks are collected anonymously around the world. This raw data is ag-gregated and processed by

All3DP GmbH, operator of a fast growing English-language Internet platform for 3D printing, has completed seven-figure Series A financing round. All3DP publishes an online magazine at All3DP.com that familiarizes broad target groups from the consumer and small business segment with 3D printing and connects users with leading 3D printing service providers. The investors of the current financing round include Deutsche Balaton AG, Bayern Kapital, High-Tech Gründerfonds (HTGF) and four private inve

Evalu is a Munich startup whose software offers athletes the opportunity to be coached at a professional level. The team of engineers, athletes, and coaches has been developing artificial intelligence software, which assesses, evaluates, and supports athletes. Recently, evalu secured seed funding with several high-profile investors from the Munich area as well as the High-Tech Gründerfonds (HTGF). The startup was aided in this endeavor through the BayStartUp GmbH and the UnternehmerTUM GmbH.